Cardio Diagnostics (CDIO) Competitors $4.28 -0.05 (-1.15%) Closing price 03:59 PM EasternExtended Trading$4.43 +0.15 (+3.60%) As of 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDIO vs. DARE, ENLV, CVKD, PASG, LPTX, PMN, LNAI, CASI, MIRA, and TAOXShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include Dare Bioscience (DARE), Enlivex Therapeutics (ENLV), Cadrenal Therapeutics (CVKD), Passage Bio (PASG), Leap Therapeutics (LPTX), Promis Neurosciences (PMN), Lunai Bioworks (LNAI), CASI Pharmaceuticals (CASI), MIRA Pharmaceuticals (MIRA), and Synaptogenix (TAOX). These companies are all part of the "pharmaceutical products" industry. Cardio Diagnostics vs. Its Competitors Dare Bioscience Enlivex Therapeutics Cadrenal Therapeutics Passage Bio Leap Therapeutics Promis Neurosciences Lunai Bioworks CASI Pharmaceuticals MIRA Pharmaceuticals Synaptogenix Dare Bioscience (NASDAQ:DARE) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability. Do insiders & institutionals hold more shares of DARE or CDIO? 6.7% of Dare Bioscience shares are held by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are held by institutional investors. 4.8% of Dare Bioscience shares are held by insiders. Comparatively, 13.3% of Cardio Diagnostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation and earnings, DARE or CDIO? Dare Bioscience has higher earnings, but lower revenue than Cardio Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDare Bioscience$10K2,736.44-$4.05M-$2.14-0.95Cardio Diagnostics$40K188.32-$8.38MN/AN/A Does the media prefer DARE or CDIO? In the previous week, Dare Bioscience and Dare Bioscience both had 1 articles in the media. Dare Bioscience's average media sentiment score of 1.82 beat Cardio Diagnostics' score of 1.45 indicating that Dare Bioscience is being referred to more favorably in the media. Company Overall Sentiment Dare Bioscience Very Positive Cardio Diagnostics Positive Which has more volatility & risk, DARE or CDIO? Dare Bioscience has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 2.91, indicating that its stock price is 191% more volatile than the S&P 500. Is DARE or CDIO more profitable? Dare Bioscience has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -30,465.10%. Dare Bioscience's return on equity of 0.00% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Dare BioscienceN/A N/A -103.70% Cardio Diagnostics -30,465.10%-72.78%-66.17% Do analysts prefer DARE or CDIO? Dare Bioscience currently has a consensus target price of $10.00, suggesting a potential upside of 392.61%. Given Dare Bioscience's stronger consensus rating and higher possible upside, equities analysts plainly believe Dare Bioscience is more favorable than Cardio Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dare Bioscience 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Cardio Diagnostics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SummaryDare Bioscience beats Cardio Diagnostics on 8 of the 13 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIO vs. The Competition Export to ExcelMetricCardio DiagnosticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.53M$3.41B$6.08B$10.54BDividend YieldN/A2.29%5.73%4.78%P/E RatioN/A22.5884.6327.10Price / Sales188.32484.96606.15130.49Price / CashN/A46.9737.8662.13Price / Book0.6010.4112.246.58Net Income-$8.38M-$52.47M$3.32B$276.75M7 Day Performance3.13%2.30%0.76%0.92%1 Month Performance10.88%14.45%8.03%4.20%1 Year Performance-32.48%12.90%71.13%37.86% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOCardio Diagnostics1.5187 of 5 stars$4.28-1.2%N/A-36.3%$7.53M$40K0.001Short Interest ↓DAREDare Bioscience2.5133 of 5 stars$2.12flat$10.00+371.7%-40.8%$28.58M$10K-0.9930Positive NewsENLVEnlivex Therapeutics3.3282 of 5 stars$1.10-4.3%$10.00+809.1%-35.2%$27.94MN/A-1.9070CVKDCadrenal Therapeutics2.9427 of 5 stars$13.99+2.7%$32.00+128.7%-10.0%$27.88MN/A-1.584PASGPassage Bio3.5003 of 5 stars$8.69+2.6%$75.67+770.7%-32.1%$26.93MN/A-0.48130Gap UpLPTXLeap Therapeutics2.6707 of 5 stars$0.60-5.5%$3.38+459.6%-76.1%$26.46MN/A-0.3840Short Interest ↓Gap UpPMNPromis Neurosciences3.8255 of 5 stars$0.48-2.0%$4.33+802.8%-55.1%$26.37MN/A-2.295Short Interest ↓Gap DownLNAILunai BioworksN/A$1.16+2.7%N/AN/A$26.19MN/A-0.1520News CoverageCASICASI Pharmaceuticals4.011 of 5 stars$1.89-4.5%$4.00+111.6%-68.5%$24.35M$28.54M-0.65180Analyst ForecastMIRAMIRA Pharmaceuticals0.4475 of 5 stars$1.29+2.0%N/A+63.6%$24.03MN/A-2.622News CoverageGap DownTAOXSynaptogenix0.0562 of 5 stars$9.54+38.5%N/AN/A$24.03MN/A-0.474Gap UpHigh Trading Volume Related Companies and Tools Related Companies DARE Competitors ENLV Competitors CVKD Competitors PASG Competitors LPTX Competitors PMN Competitors LNAI Competitors CASI Competitors MIRA Competitors TAOX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIO) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
